Optimization of PLGA nanoparticles formulation containing L-DOPA by applying the central composite design

Area of Science:

• Nanotechnology
• Materials Science
• Pharmaceutical Sciences

Background:

• Levodopa (L-DOPA) is a crucial drug for Parkinson's disease treatment.
• Effective delivery of L-DOPA to the brain remains a challenge.
• Poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles offer a potential solution for controlled drug delivery.

Purpose of the Study:

• To prepare and optimize L-DOPA loaded PLGA nanoparticles using a modified water-in-oil-in-water emulsification solvent evaporation method.
• To investigate the impact of formulation parameters on particle size and entrapment efficiency.
• To identify optimal conditions for nanoparticle preparation for enhanced L-DOPA delivery.

Main Methods:

• Modified water-in-oil-in-water (W(1)/O/W(2)) emulsification solvent evaporation technique.
• Central composite design for optimizing poly(D,L-lactide-co-glycolide) (PLGA) concentration, polyvinyl alcohol (PVA) concentration, and organic solvent removal rate.
• Fourier-transform infrared (FTIR) spectroscopy and scanning electron microscopy (SEM) for characterization.

Main Results:

• Second-order models accurately described the influence of independent variables on particle size and entrapment efficiency.
• Optimal conditions identified: 5% PLGA, 6% PVA, and 700 rpm solvent removal rate.
• Achieved particle size of 256.2 nm and entrapment efficiency of 62.19%.
• FTIR confirmed structural integrity of L-DOPA and PLGA.
• SEM revealed spherical nanoparticles with porous outer skins.

Conclusions:

• The central composite design effectively optimized the preparation of L-DOPA loaded PLGA nanoparticles.
• PLGA nanoparticles demonstrate potential as a promising formulation for brain delivery of L-DOPA.
• Optimized nanoparticles exhibit suitable characteristics for enhanced therapeutic efficacy.